Literature DB >> 24170604

Self-reported exercise and bone mineral density in prostate cancer patients receiving androgen deprivation therapy.

Lori J Mennen-Winchell1, Victor Grigoriev, Patricia Alpert, Hildemar Dos Santos, Serena Tonstad.   

Abstract

PURPOSE: Men with prostate cancer receiving androgen deprivation therapy (ADT) are at increased risk for decreased bone mineral density (BMD). This study evaluates the relationship between self-reported daily activity, endurance and resistance exercise, and BMD measured by dual-energy x-ray absorptiometry (DEXA) in prostate cancer patients receiving ADT. DATA SOURCES: We recruited 96 men treated with ADT for ≥9 months from urology and cancer practices. The Canadian Fitness Survey assessed daily activity and exercise. Data on demographic and lifestyle characteristics and calcium and vitamin D supplementation were collected. Blood was collected for analysis of 25-OH vitamin D. A DEXA scan was performed.
CONCLUSIONS: A positive association between endurance exercise and DEXA T-scores of the hip was shown. Regression analysis showed endurance exercise of medium to heavy intensity (measured as energy expenditure in MET-hours/week) was associated with T-scores of the hip (β = 0.048; 95% CI 0.003, 0.112; p = .040) but not with spinal T-scores after controlling for age, body mass index, and alcohol use. IMPLICATIONS FOR PRACTICE: Findings are cross-sectional, but if confirmed in prospective studies suggest that increased endurance exercise is a practical measure nurse practitioners can institute to prevent low bone density in the hip of men treated with ADT. ©2013 The Author(s) ©2013 American Association of Nurse Practitioners.

Entities:  

Keywords:  Androgen ablation therapy; cancer, bone mineral density; exercise

Mesh:

Substances:

Year:  2013        PMID: 24170604     DOI: 10.1002/2327-6924.12066

Source DB:  PubMed          Journal:  J Am Assoc Nurse Pract        ISSN: 2327-6886            Impact factor:   1.165


  2 in total

1.  Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis.

Authors:  F Vescini; R Attanasio; A Balestrieri; F Bandeira; S Bonadonna; V Camozzi; S Cassibba; R Cesareo; I Chiodini; C Maria Francucci; L Gianotti; F Grimaldi; R Guglielmi; B Madeo; C Marcocci; A Palermo; A Scillitani; E Vignali; V Rochira; M Zini
Journal:  J Endocrinol Invest       Date:  2016-03-11       Impact factor: 4.256

2.  The effects of exercise on body composition of prostate cancer patients receiving androgen deprivation therapy: An update systematic review and meta-analysis.

Authors:  Wenjuan Shao; Hanyue Zhang; Han Qi; Yimin Zhang
Journal:  PLoS One       Date:  2022-02-15       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.